Lipid-lowering drug therapy for reducing cardiovascular risk in diabetes. A clinical view of the Cardiovascular Disease Working Group of the Spanish Diabetes Society Juan Pedro-Botet; Francisco Arrieta; Manuel Botana; José A. Gimeno-Orna; José I. Martínez-Montoro; Emilio Ortega-Martínez de Victoria; Josep Ribalta; Víctor Sánchez-Margalet; Antonio Pérez-Pérez;

Impact of the presence and type of cardiovascular disease on the risk of mortality in type 2 diabetic patients: The DIABET-IC trial José Antonio Gimeno Orna; Ana Belén Mañas Martínez; Luis Rodríguez Padial; Manuel Anguita Sánchez; Vivencio Barrios; Javier Muñiz García; Antonio Pérez Pérez;

Second edition of the ¿do not do¿ recommendations from the Spanish Society of Endocrinology and Nutrition (SEEN) Juan José Díez; Manuel Gargallo Fernández; José Antonio Gimeno Orna; Elena González Arnaiz; Isabel Huguet Moreno; Sílvia Martínez Couselo; María Miguélez González; María Julia Ocón; Gilberto Pérez López; Francisco Pita Gutiérrez; Jordi Luis Reverter Calatayud; Cristina Tejera Pérez; Eulàlia Urgell Rull; Alberto Fernández;